Comparison of Effectiveness Between Intralesional Triamcinolone Injections and Incision and Curettage for the Primary Chalazia
Journal of the Korean Ophthalmological Society
;
: 1488-1493, 2013.
Article
Dans Coréen
| WPRIM
| ID: wpr-27321
ABSTRACT
PURPOSE:
To evaluate the effectiveness of intralesional triamcinolone acetonide injection, and incision and curettage for primary chalazia.METHODS:
In order to compare the effectiveness of treatment modality, 103 patients who were diagnosed with primary chalazia were divided into 2 groups. The patients in group A underwent intralesional triamcinolone acetonide injection and the patients in group B underwent incision and curettage. The patients were followed up 1 week and 3 weeks after the procedures to identify the regression of the lesion and the procedure complications. A decision regarding success or failure was made at 3 and 6 weeks after the treatment. Successful treatment was defined as the infallibility in the functional and esthetic aspects as well as the size of regressed lesion.RESULTS:
This study included 82 out of 103 patients, who satisfied the inclusion criteria. Forty-four patients underwent intralesional triamcinolone acetonide injection and the remaining 38 patients underwent incision and curettage. The success rate of the initial treatment, which was identified 3 weeks after the procedure, was 81.8% in group A and 86.8% in group B. The cumulative success rate of treatment after 6 weeks was 86.8% in group A and 92.1% in group B. No complications were observed with both treatment modalities.CONCLUSIONS:
Intralesional triamcinolone acetonide injection is as effective and safe as incision and curettage for the treatment of primary chalazia.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Triamcinolone
/
Triamcinolone acétonide
/
Chalazion
/
Curetage
Type d'étude:
Étude pronostique
Limites du sujet:
Humains
langue:
Coréen
Texte intégral:
Journal of the Korean Ophthalmological Society
Année:
2013
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS